Content Video
AI-Powered CQV That’s Still Audit-Ready: What "Good" Looks Like
0:08 - AI can now execute validation work faster than ever.
0:12 - But if you can't show who approved what, which version was used,
0:16 - or where the evidence came from, you didn't modernize CQV,
0:20 - you created a new audit risk.
0:22 - The goal isn't just faster documents, it's a governed AI validation workforce
0:27 - operating inside the validation system of record.
0:31 - 4 guardrails make AI-Powered CQV audit ready
0:35 - Controlled content reuse, built from approved templates and validated building blocks.
0:40 - Human review, SMEs and QA still own every decision
0:43 - audit trails, every change is tracked and explainable.
0:47 - Change control updates follow governed life cycle workflows.
0:51 - Inside a connected validation platform, AI can generate protocols,
0:55 - guide execution, and link evidence while every step
0:58 - remains controlled.
0:59 - So when an auditor asks for the validation record,
1:02 - you can pull it up instantly.
1:04 - See how a governed AI validation workforce transforms CQV.
1:08 - Visit valgenesis.com.
Summary
AI can accelerate validation work, but speed without control introduces audit risk. If approvals, version history, and evidence traceability are unclear, validation efforts may fail inspection despite faster execution.
A governed AI validation workforce operates within a controlled system, combining automation with oversight. With structured guardrails, organizations can generate, execute, and manage validation while maintaining full audit readiness and instant access to records.
Key Takeaways
• AI in CQV must operate within controlled systems to remain audit-ready.
• Human oversight, audit trails, and governed workflows ensure compliance.
• Connected platforms enable fast validation with full traceability and instant record access.
Who is this for
• Validation Engineers
• Quality Assurance Professionals
• CQV Specialists
• Regulatory Affairs Professionals
• Manufacturing Engineers in Life Sciences
• Compliance Officers
• Digital Transformation Leaders in Pharma/Biotech
Relevant Entities
• FDA (U.S. Food and Drug Administration) – https://www.fda.gov
• European Medicines Agency (EMA) – https://www.ema.europa.eu
• 21 CFR Part 11 – https://www.ecfr.gov/current/title-21/part-11
• EU Annex 11 – https://health.ec.europa.eu
• ALCOA+ Principles – https://www.fda.gov
